Literature DB >> 26949990

Infection in cystic fibrosis: impact of the environment and climate.

K A Ramsay1,2,3, R E Stockwell1, S C Bell1,3,4, T J Kidd2,5,6.   

Abstract

In many countries numbers of adults with cystic fibrosis (CF) exceed that of children, with median survival predicted to surpass 50 years. Increasing longevity is, in part, due to intensive therapies including eradication of early infection and suppressive therapies and pulmonary exacerbations. Initial infections with common CF pathogens are thought to arise from the natural environment. We review the impact of climate and environment on infection in CF. Specifically, several studies indicate that higher ambient temperatures, proximity to the equator and the summer season may be linked to the increased prevalence of Pseudomonas aeruginosa in people with CF. The environment may also play an important role in the acquisition of Gram negative organisms other than P. aeruginosa. There is emerging data suggesting that climatic and environmental factors are likely to impact on the risk of infection with NTM and fungi in people which are found extensively throughout the natural environment.

Entities:  

Keywords:  Cystic fibrosis; Pseudomonas aeruginosa; acquisition; climate; environmental microbiology; epidemiology; fungi; infection; nontuberculous mycobacteria; travel

Mesh:

Year:  2016        PMID: 26949990     DOI: 10.1586/17476348.2016.1162715

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  7 in total

1.  Tensin 1 (TNS1) is a modifier gene for low body mass index (BMI) in homozygous [F508del]CFTR patients.

Authors:  Nathan I Walton; Xijun Zhang; Anthony R Soltis; Joshua Starr; Clifton L Dalgard; Matthew D Wilkerson; Douglas Conrad; Harvey B Pollard
Journal:  Physiol Rep       Date:  2021-06

2.  Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.

Authors:  Kevin J Psoter; Anneclaire J De Roos; Jon Wakefield; Jonathan D Mayer; Margaret Rosenfeld
Journal:  BMC Pulm Med       Date:  2017-07-27       Impact factor: 3.317

Review 3.  Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis.

Authors:  Renee N Ng; Anna S Tai; Barbara J Chang; Stephen M Stick; Anthony Kicic
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

Review 4.  Gene therapy for cystic fibrosis: new tools for precision medicine.

Authors:  Alex Cho; Elena N Huang; Jin-A Lee; Yiming Xu; Henry Quach; Jim Hu; Amy P Wong
Journal:  J Transl Med       Date:  2021-10-30       Impact factor: 5.531

Review 5.  The Impact of Air Pollution on the Course of Cystic Fibrosis: A Review.

Authors:  Marion Blayac; Patrice Coll; Valérie Urbach; Pascale Fanen; Ralph Epaud; Sophie Lanone
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

Review 6.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

7.  Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations.

Authors:  Tavs Qvist; Daniela K Schlüter; Vian Rajabzadeh; Peter J Diggle; Tania Pressler; Siobhán B Carr; David Taylor-Robinson
Journal:  J Cyst Fibros       Date:  2018-10-19       Impact factor: 5.482

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.